Liver Disease

Latest News
November 20th 2024

New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease

March 14th 2024

FDA Approves Resmetirom, First Treatment for NASH With Liver Fibrosis

August 17th 2023

Statin Prescribing Patterns in Patient-Centered Medical Home Patients With NAFLD

December 12th 2022

Impact of Direct-Acting Antiviral Use for Chronic Hepatitis C on Health Care Costs in Medicaid: Economic Model Update

November 30th 2022

Pathological Neutrophil Migration in Cirrhosis Linked to Increased Risk of AEs

Video Interviews
View All
November 24th 2022

Dr Nancy Reau on How to Educate Providers on Liver Disease Guidelines

November 19th 2022

Dr Nancy Reau Covers Alcohol Use Disorder Interventions to Prevent Alcoholic Hepatitis

November 17th 2022

Dr Nancy Reau: COVID-19, Drinking Patterns, Lifestyle Factors Causing Increased Alcoholic Hepatitis Hospitalizations

November 8th 2022

Provider Knowledge on Liver Disease Guidelines Varies, Dr Nancy Reau Says

November 1st 2019

Dr Karen Watkins Details the Obstacles Impeding Effective Treatment for Patients With NASH

Podcasts
View All
August 7th 2018

Discussing Increased Prevalence of NAFLD and NASH, and the Current Lack of Treatments

Continuing Medical Education
View All
November 21st 2024

Navigating Next-Generation Therapies for the Management of Acid-Related Disorders

1.5 Credits / Gastroenterology
November 21st 2024

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

More News

4 surgeons performing surgery
November 21st 2022

MA Beneficiaries May Be at Disadvantage for Complex Cancer Surgeries

Hayden E. Klein
Patients with Medicare Advantage (MA) were 1.5 times more likely to die within a month of surgical removal of their stomach or liver, and twice as likely to die within a month of oncologic surgery of the pancreas, compared with patients with traditional Medicare.
cigarette in ashtray
November 3rd 2022

Change in Smoking Status and Subsequent BMI Change Linked to NAFLD Risk

Hayden E. Klein
Across 4 types of smoking status groups, nonalcoholic fatty liver disease (NAFLD) risk significantly increased among participants who saw an increase in body mass index (BMI) and decreased among participants whose BMI went down.
image of liver
October 29th 2022

Second Liver Health Annual Trends Report Offers Insight Concerning CLD Management and Care

Pearl Steinzor
Challenges to the care of chronic liver disease (CLD) include the burden of costs, managed and multidisciplinary care issues, and the lack of awareness for clinical guidelines.
doctor writing on clipboard with stethoscope
October 26th 2022

New ICD-10 Code Aims to Provide More Insight Into Hepatic Encephalopathy

Hayden E. Klein
In an interview, the section chief of hepatology at Rush University Medical Center discussed why the addition of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code K76.82 is necessary.
What We're Reading
October 26th 2022

What We’re Reading: Surge in Black, Latino ACA Enrollment; Medicaid Enrollment, Spending Trends; US Hepatitis C Treatment Plan

AJMC Staff
Black and Latino Americans saw surges in health care insurance enrollment through the Affordable Care Act (ACA) between 2020 and 2022; Medicaid enrollment and spending is expected to slow in 2023; the Biden administration is preparing a national hepatitis C treatment plan.
liver
October 22nd 2022

Livers Can Function for 100 Years and Potentially Expand Pool of Eligible Donors

AJMC Staff
New research is identifying the recipient and donor factors that allow for greater longevity for certain livers after transplantation.
person with IV in hand
October 21st 2022

Albumin Injections Linked to Improved Brain Function, QOL in Patients With Liver Cirrhosis

Hayden E. Klein
Researchers also found an improvement in specialized blood markers focusing on inflammation, endothelial dysfunction, and albumin function in patients receiving weekly albumin injection.
close up of Europe on globe, shaded blue
October 15th 2022

European Report Highlights Health, Economic Impacts of Digestive Diseases

Hayden E. Klein
Chronic liver disease and pancreatitis were among the digestive diseases with high increases in incidence and mortality since 2000.
doctor checking liver
October 11th 2022

ICER to Assess Clinical Effectiveness, Value of 2 NASH Treatments

Laura Joszt, MA
There are no FDA-approved therapies for nonalcoholic steatohepatitis (NASH), but there are many being developed. Resmetirom and obeticholic acid are both being reviewed by the FDA with decisions expected in 2023.
liver and dna strand graphic
October 7th 2022

Higher Risk of Liver Disease Progression Seen Among Patients With PNPLA3 I148M Variant

Hayden E. Klein
Individuals who were homozygous carriers of the PNPLA3 I148M genetic variant and reported excessive drinking and obesity had a 17.5 to 30.1 higher risk of progression to liver disease complications.
doctor holding stethoscope to animated liver
September 27th 2022

NAFLD Linked to Increased Risk of Metabolic Syndrome in Patients Without MAFLD

Hayden E. Klein
Among individuals without metabolic-associated fatty liver disease (MAFLD), those with nonalcoholic fatty liver disease (NAFLD) had a higher risk of developing metabolic syndrome.
gut microbiome
September 24th 2022

Study Identifies Gut Microbiota Linked to HE Pathophysiology

Hayden E. Klein
Urease-positive Streptococcus salivarius was the most significantly abundant gut microbiota in patients with HE.
Pichamol Jirapinyo, MD, MPH
September 22nd 2022

Dr Pichamol Jirapinyo Discusses Endoscopic Gastric Plication in Patients With NAFLD

Hayden E. Klein
Pichamol Jirapinyo, MD, MPH, director of bariatric endoscopy fellowship at Brigham and Women's Hospital, explains the implications of her study on the effects of endoscopic gastric plication on liver fibrosis in patients with nonalcoholic steatohepatitis (NASH).
emergency department
September 16th 2022

Optimizing Emergency Care Processes Improves Outcomes for Hospitalized Patients With HE

Laura Joszt, MA
Patients with hepatic encephalopathy (HE) often do not seek care until they are in critical condition, making an optimized emergency care process critical to reduce adverse prognosis and improve clinical symptoms.
Fruits and vegetables
September 14th 2022

Review Outlines Nutrition Assessment, Management in Patients With Cirrhosis

Julia Bonavitacola
A comprehensive review assessed the ways that proper nutrition could help reduce the adverse effects of hepatic encephalopathy in patients with hepatic encephalopathy.
silhouette of woman's face highlighting brain
September 9th 2022

Rifaximin Plus Lactulose Linked to Greater Effectiveness, Decreased Mortality in HE

Hayden E. Klein
Compared with the use of lactulose alone, rifaximin plus lactulose can provide additional benefits in terms of increased effectiveness rate and decreased mortality in patients with hepatic encephalopathy (HE).
doctor reading textbook
September 3rd 2022

Evidence-Based Management Options for Hepatic Encephalopathy Explored in New Review

Hayden E. Klein
A review of 6 studies on treatment options for hepatic encephalopathy found that many require further research before they can be recommended.
Map of Europe
September 2nd 2022

Liver Disease Disparities Rarely Studied in Europe, Review Finds

Jared Kaltwasser
A new analysis found only 1 in 10 studies of inequities in liver cancer had a European focus or origin.
Individualized Antimicrobial Treatment, Prophylactic Regimens May Help With GVHD After Liver Transplant
June 3rd 2022

Individualized Antimicrobial Treatment, Prophylactic Regimens May Help With GVHD After Liver Transplant

Rose McNulty
A recent study aimed to provide insight and guidance for managing graft-versus-host disease in patients after liver transplantation.
Liver assessment.
May 31st 2022

Study Finds Link Between Psoriasis, NAFLD Among US Adult Outpatients

Matthew Gavidia
US adult outpatients with psoriasis have a greater risk of developing nonalcoholic fatty liver disease compared with those without the skin condition.
ASTRO Offers Guidance on EBRT for Primary Liver Cancers
February 14th 2022

ASTRO Offers Guidance on EBRT for Primary Liver Cancers

AJMC Staff
Liver illustration
January 23rd 2022

Contributor: Empowering Endocrinologists With Technology for the Diagnosis, Management, and Treatment of NAFLD

Juan Pablo Frias, MD
In this column, an endocrinologist discusses the growing problem of liver disease and new options at their disposal, including vibration-controlled transient elastography.
Top 5 Most-Read Liver Disease Articles of 2021
December 28th 2021

Top 5 Most-Read Liver Disease Articles of 2021

Allison Inserro
Chronic liver disease is on the rise and the burden is expected to increase in the future, both in the United States and around the world. These are the most-read articles about liver disease in 2021.
Posters Review Surveillance of Patients With NAFLD to Identify HCC
December 22nd 2021

Posters Review Surveillance of Patients With NAFLD to Identify HCC

Laura Joszt, MA
Two posters presented at The Liver Meeting evaluated nonalcoholic fatty liver disease (NAFLD)–associated hepatocellular carcinoma (HCC) to understand the burden and identify the risk for developing HCC.
Study Finds First-Degree Family History of Diabetes Linked With NAFLD
December 19th 2021

Study Finds First-Degree Family History of Diabetes Linked With NAFLD

AJMC Staff
Using the fatty liver index (FLI) to identify nonalcoholic fatty liver disease (NAFLD), researchers sought to understand the association between first-degree family members of patients with diabetes and NAFLD.
Liver management
December 13th 2021

Educational Interventions Are Needed to Address Knowledge Gaps for Management of NASH

Laura Joszt, MA
Two posters presented at The Liver Meeting identified the primary care coordinators for patients with nonalcoholic steatohepatitis (NASH) and areas of unmet need among specialists to provide optimal management.
disparities
December 11th 2021

Evaluating Factors Impacting Health Disparities in Liver Transplant

Laura Joszt, MA
Posters review how a patient’s neighborhood impacts access to the liver transplant waitlist and how Medicaid expansion improved waitlist mortality.
Obesity workout
December 10th 2021

Dedicated Intervention Can Achieve Weight Loss in Patients With NALFD

Laura Joszt, MA
Guidelines recommend patients with nonalcoholic fatty liver disease (NAFLD) who are obese achieve 5% to 10% weight loss to prevent NAFLD progression.
Patients With NAFLD Have Higher Risk of HF, Study Finds
December 4th 2021

Patients With NAFLD Have Higher Risk of HF, Study Finds

Allison Inserro
Specifically, patients with nonalcoholic fatty liver disease (NAFLD) have a higher risk of developing heart failure (HF) with preserved ejection fraction, according to new research.
scale
December 3rd 2021

Healthy Eating, Exercise Encouraged to Help Improve QOL in NAFLD

Gianna Melillo
Authors of a review published in Hormones outlined the benefits of healthy eating and physical activity to prevent and improve non-alcoholic fatty liver disease.
123>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo